Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT01080326Not ApplicableCompleted

Feasibility of Translumenal Endoscopic Omental Patch Closure of Perforated Viscus

Role: collaborator

NCT01189916Not ApplicableCompleted

Transrectal NOTES Appendectomy - Feasibility Study

Role: collaborator

NCT00816179Not ApplicableTerminated

Diagnostic Endoscopic Exploration for Pancreatic Head Mass

Role: collaborator

NCT00610025Not ApplicableCompleted

Minimally Invasive Trocar Placement in Obesity Surgery

Role: collaborator

NCT01171027Not ApplicableUnknown

Prospective Multicenter Human Randomized Controlled Evaluation of NOTES® Cholecystectomy

Role: lead

All 5 trials loaded